Heartland Advisors Inc. Has $25.84 Million Stock Holdings in Teleflex Incorporated $TFX

Heartland Advisors Inc. grew its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 107.8% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 215,998 shares of the medical technology company’s stock after purchasing an additional 112,071 shares during the period. Teleflex comprises 1.3% of Heartland Advisors Inc.’s holdings, making the stock its 6th largest holding. Heartland Advisors Inc.’s holdings in Teleflex were worth $25,836,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in TFX. Banque Cantonale Vaudoise raised its position in shares of Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares in the last quarter. V Square Quantitative Management LLC acquired a new stake in Teleflex during the fourth quarter worth approximately $37,000. UMB Bank n.a. grew its position in Teleflex by 57.1% during the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after buying an additional 113 shares in the last quarter. Sound Income Strategies LLC acquired a new stake in Teleflex during the fourth quarter worth approximately $45,000. Finally, Kestra Advisory Services LLC bought a new position in Teleflex during the 4th quarter worth $45,000. 95.62% of the stock is owned by institutional investors.

Teleflex Trading Down 0.2%

Shares of Teleflex stock opened at $134.96 on Friday. The firm’s 50 day moving average is $130.48 and its 200 day moving average is $120.49. The firm has a market capitalization of $5.97 billion, a PE ratio of -5.92, a price-to-earnings-growth ratio of 1.00 and a beta of 0.82. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $139.67. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. During the same period in the prior year, the company earned $1.44 EPS. Teleflex’s revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts forecast that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend was Friday, May 22nd. Teleflex’s payout ratio is presently -5.96%.

Analyst Upgrades and Downgrades

TFX has been the subject of several analyst reports. Bank of America raised Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price objective for the company in a report on Monday, April 13th. Wells Fargo & Company increased their target price on Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a report on Friday, May 8th. Truist Financial restated a “hold” rating and issued a $143.00 price target (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. BMO Capital Markets initiated coverage on Teleflex in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 price target for the company. Finally, Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and boosted their price target for the company from $135.00 to $155.00 in a research note on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Teleflex presently has an average rating of “Hold” and a consensus price target of $148.00.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.